IM Cannabis (IMCC) Net Equity Issued and Repurchased (2021 - 2024)
IM Cannabis (IMCC) posted quarterly Net Equity Issued and Repurchased of -$128680.7 for Q2 2024, down 120.03% year-over-year from $642462.5 in Q3 2023, and down 198.52% quarter-over-quarter from $130611.9 in Q1 2024.
IM Cannabis (IMCC) Net Equity Issued and Repurchased (2021 - 2024) Analysis & Trends
IM Cannabis' Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at -$128680.7 for Q2 2024.
- In Q2 2024, Net Equity Issued and Repurchased fell 120.03% year-over-year to -$128680.7; the TTM figure through Jun 2024 stood at $644393.7 (down 84.34% YoY), while the FY2022 annual figure was $2.9 million, down 87.13% from the prior year.
- Net Equity Issued and Repurchased for Q2 2024 stood at -$128680.7, down from $130611.9 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $2.4 million in Q3 2022, with the low at -$8.9 million in Q4 2021.
- The 4-year median for Net Equity Issued and Repurchased is $428761.1 (2022), against an average of -$683680.1.
- The sharpest annual moves came in 2022 and 2024: Net Equity Issued and Repurchased surged 104.82% in 2022, then sank 120.03% in 2024.
- IM Cannabis' Net Equity Issued and Repurchased stood at -$8.9 million in 2021, then soared by 104.82% to $428761.1 in 2022, then surged by 49.84% to $642462.5 in 2023, then tumbled by 120.03% to -$128680.7 in 2024.
- Business Quant data shows IMCC's Net Equity Issued and Repurchased at -$128680.7 in Q2 2024, $130611.9 in Q1 2024, and $642462.5 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -128,680.74 |
| Jun 30, 2024 | -128,680.74 |
| Mar 31, 2024 | 130,611.92 |
| Mar 31, 2024 | 130,611.92 |
| Jun 30, 2023 | 642,462.48 |
| Jun 30, 2023 | 642,462.48 |
| Mar 31, 2023 | 610,249.50 |
| Mar 31, 2023 | 610,249.50 |
| Dec 31, 2022 | 428,761.11 |
| Dec 31, 2022 | 428,761.11 |
| Sep 30, 2022 | 2.43 Mn |
| Sep 30, 2022 | 2.43 Mn |
| Dec 31, 2021 | -8.90 Mn |
| Dec 31, 2021 | -8.90 Mn |